SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-031200
Filing Date
2022-06-03
Accepted
2022-06-03 16:55:44
Documents
9
Period of Report
2022-06-03

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea160517-6k_mainzbio.htm 6-K 11421
2 ANNOUNCEMENT OF ANNUAL GENERAL MEETING ea160517ex99-1_mainzbio.htm EX-99.1 1463
3 NOTICE OF ANNUAL GENERAL MEETING ea160517ex99-2_mainzbio.htm EX-99.2 14749
4 AGENDA OF THE ANNUAL GENERAL MEETING ea160517ex99-3_mainzbio.htm EX-99.3 27793
5 VOTING PROXY ea160517ex99-4_mainzbio.htm EX-99.4 2125
6 FORM OF REMUNERATION POLICY ea160517ex99-5_mainzbio.htm EX-99.5 47923
7 FORM OF 2022 OMNIBUS INCENTIVE PLAN ea160517ex99-6_mainzbio.htm EX-99.6 168803
8 GRAPHIC ex99-4_001.jpg GRAPHIC 139048
9 GRAPHIC ex99-4_002.jpg GRAPHIC 132481
  Complete submission text file 0001213900-22-031200.txt   649482
Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Filer) CIK: 0001874252 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41010 | Film No.: 22995448
SIC: 2834 Pharmaceutical Preparations